Author

J. Ravits

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. D. Boyer· 1 shared A. D. Parisian· 1 shared A. Goginashvili· 1 shared C. C. Chen· 1 shared C. Liu· 1 shared D. W. Cleveland· 1 shared F. B. Furnari· 1 shared F. M. Hessenauer· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. D. Boyer

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Heat shock chaperone HSPB1 regulates cytoplasmic TDP-43 phase separation and liquid-to-gel transition

S. Lu, J. Hu, O. A. Arogundade, A. Goginashvili, S. Vazquez-Sanchez, J. K. Diedrich, J. Gu, J. Blum, S. Oung, H. Yu, J. Ravits, C. Liu, J. R. Yates, D. W. Cleveland

This study shows HSPB1 regulates cytoplasmic TDP-43 phase separation and liquid-to-gel transition, with implications for neurodegenerative diseases like ALS.

bioRxiv · Oct 14, 2021Cell Biology

Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development

T. Koga, J. A. Benitez, I. A. Chaim, S. Markmiller, A. D. Parisian, R. F. Hevner, K. M. Turner, F. M. Hessenauer, M. D'Antonio, N.-p. D. Nguyen, S. Saberi, J. Ma, S. Miki, A. D. Boyer, J. Ravits, , F. B. Furnari

This paper introduces cancer avatar models using genetically engineered hiPSCs to study tumor development and heterogeneity in glioblastoma.

bioRxiv · Oct 25, 2019Cancer Biology